Home
Clinical Resources Search
PQI: DPYD Testing Prior to Fluoropyrimidine Treatment

DPYD Testing Prior to Fluoropyrimidine Treatment

Last Updated: May 22, 2024

By: Dan Hertz, PharmD, PhD

About this PQI

The purpose of this PQI is to review recommendations for DPYD testing prior to initiation of treatment with fluoropyrimidine based chemotherapy and increase awareness of the clinical benefit of pretreatment DPYD testing.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

DPYD Testing Prior to Fluoropyrimidine Treatment

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia

PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

PQI in Action: Abiraterone acetate (Yonsa) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E11: Honoring Veterans Through Early Cancer Detection

S9 E10: Advancing Clinical Research

S9 E9: The Realities of Ethics in Oncology

S9 E8: Mental Strength at Work

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

S8 Ep 10: Operationalizing Bispecifics in the Community Setting

The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team

The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings

The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program

PQI in Action: Larotrectinib (Vitrakvi) Overview

PQI Podcast S6 Ep 9: ctDNA Testing in GI Cancers

PQI Podcast S6 Ep 2: Molecular Testing & Targeted Treatment in Colorectal Cancer

PQI: Selpercatinib (Retevmo®) Genomic Testing Management

Capecitabine and Cisplatin

Capecitabine and Mitomycin with Radiation Therapy

Tislelizumab, Capecitabine, and Cisplatin

Pembrolizumab, Capecitabine, and Cisplatin

Durvalumab and FLOT

Fluorouracil and Mitomycin with Radiation Therapy

Tislelizumab and FOLFOX

Fluorouracil and Cisplatin